- Home
- QNCX vs CFBK Comparison
QNCX vs CFBK Comparison
Compare QNCX & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QNCX | CFBK |
|---|---|---|
| Founded | 2012 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.0M | 184.4M |
| IPO Year | 2019 | 1998 |
Fundamental Metrics
Financial Performance| Metric | QNCX | CFBK |
|---|---|---|
| Price | $0.18 | $32.01 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $10.00 | ★ $29.00 |
| AVG Volume (30 Days) | ★ 142.3M | 62.7K |
| Earning Date | 03-23-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 1.13% |
| EPS Growth | N/A | ★ 30.58 |
| EPS | N/A | ★ 2.69 |
| Revenue | N/A | ★ $52,703,000.00 |
| Revenue This Year | N/A | $32.28 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.83 |
| Revenue Growth | N/A | ★ 16.91 |
| 52 Week Low | $0.13 | $19.23 |
| 52 Week High | $4.55 | $34.34 |
Technical Indicators
Market Signals| Indicator | QNCX | CFBK |
|---|---|---|
| Relative Strength Index (RSI) | 27.90 | 67.84 |
| Support Level | $0.13 | $31.39 |
| Resistance Level | $0.98 | $34.34 |
| Average True Range (ATR) | 0.32 | 1.05 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 1.72 | 60.36 |
Price Performance
Historical ComparisonAbout QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.